SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934
(Amendment No. 25)

BELLUS HEALTH INC.

(Name of Company)

COMMON SHARES, NO PAR VALUE
(Title of class of securities)

07986A101

(CUSIP Number)

Dr. Francesco Bellini
Chairman and Chief Executive Officer
BELLUS Health Inc.
275 Armand Frappier Blvd.
Laval, Quebec H7V 4A7, Canada
(450) 680-4500

(Persons Authorized to Receive Notices and Communications)

June 3, 2009

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o


CUSIP No.		07986A101	Schedule 13D	Page		2		of		24 pages


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Picchio Pharma Inc.


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

	N/A

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	Canada

		7	SOLE VOTING POWER

NUMBER OF			0

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			11,450,429

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			0

WITH:		10	SHARED DISPOSITIVE POWER

			11,450,429

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	11,450,429

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	22.2%

14	TYPE OF REPORTING PERSON

	HC, CO


CUSIP No.		07986A101	Schedule 13D	Page		3		of		24 pages

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
FMRC Family Trust

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS (SEE INSTRUCTIONS)

N/A

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Alberta

SOLE VOTING POWER

NUMBER OF

20,124,000¹

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

11,706,468²

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

20,124,000¹

WITH:

SHARED DISPOSITIVE POWER

11,706,468²

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

31,830,468²

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

44.4%

TYPE OF REPORTING PERSON

¹ Reflects the number of Common Shares that are issuable on conversion of the 20,124,000 Preferred Shares held by FMRC

² As described in Item 4 of Amendment No. 17, FMRC is deemed to share beneficial ownership of the Common Shares owned by Picchio. Of the Common Shares held by Picchio, Alberta, a wholly owned subsidiary of FMRC, has the right to receive 5,725,215 Common Shares from Picchio, while VSV has the right to receive 5,725,214 Common Shares from Picchio, on or before June 30, 2009.


CUSIP No.		07986A101	Schedule 13D	Page		4		of		24 pages


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) John W. Churchill


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

	N/A

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	Canada

		7	SOLE VOTING POWER

NUMBER OF			20,124,000

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			11,706,468

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			20,124,000

WITH:		10	SHARED DISPOSITIVE POWER

			11,706,468

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	31,830,468

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	44.4%

14	TYPE OF REPORTING PERSON

	IN


CUSIP No.		07986A101	Schedule 13D	Page		5		of		24 pages


1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Vernon H. Strang


2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
	(a) o
	(b) o

3	SEC USE ONLY



4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

	N/A

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

	o

6	CITIZENSHIP OR PLACE OF ORGANIZATION

	Canada

		7	SOLE VOTING POWER

NUMBER OF			20,124,000

SHARES		8	SHARED VOTING POWER
BENEFICIALLY
OWNED BY			11,706,468

EACH		9	SOLE DISPOSITIVE POWER
REPORTING
PERSON			20,124,000

WITH:		10	SHARED DISPOSITIVE POWER

			11,706,468

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

	31,830,468

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

	o

13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

	44.4%

14	TYPE OF REPORTING PERSON

	IN


CUSIP No.		07986A101	Schedule 13D	Page		6		of		24 pages

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Victoria Square Ventures Inc.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS (SEE INSTRUCTIONS)

N/A

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

SOLE VOTING POWER

NUMBER OF

22,844,704³

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

11,450,429⁴

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

22,844,704³

WITH:

SHARED DISPOSITIVE POWER

11,450,429⁴

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

34,295,133⁴

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

46.0%

TYPE OF REPORTING PERSON

HC, CO

³ Includes 21,672,000 Common Shares that are issuable on conversion of the 21,672,000 Preferred Shares held by VSV.

⁴ Includes 11,450,429 Common Shares held through Picchio. Of the Common Shares held by Picchio, VSV has the right to receive 5,725,214 Common Shares from Picchio, while Alberta has the right to receive 5,725,215 Common Shares from Picchio, on or before June 30, 2009.


CUSIP No.		07986A101	Schedule 13D	Page		7		of		24 pages

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Dr. Francesco Bellini

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS (SEE INSTRUCTIONS)

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

SOLE VOTING POWER

NUMBER OF

798,541⁵

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

1,461,822⁶

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

798,541⁵

WITH:

SHARED DISPOSITIVE POWER

1,461,822⁶

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,260,363

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

4.3%

TYPE OF REPORTING PERSON

⁵ Includes 178,541 Common Shares directly owned by Dr. Bellini, 480,000 Common Shares issuable under currently exercisable options (including 170,000 currently exercisable options held by Picchio International Inc., an entity controlled by Dr. Bellini), and 140,000 Common Shares which Dr. Bellini is entitled to receive pursuant to the Agreement with the Company dated as of December 1, 2004 disclosed in Amendment No. 6 hereto, and for which regulatory and shareholder approval have been obtained.

⁶ Includes 1,461,822 Common Shares held of record by Dr. Bellini’s wife, Marisa Bellini, which Dr. Bellini may be deemed to own beneficially, but as to which he disclaims beneficial ownership.


CUSIP No.		07986A101	Schedule 13D	Page		8		of		24 pages

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Roberto Bellini

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS (SEE INSTRUCTIONS)

N/A

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

SOLE VOTING POWER

NUMBER OF

30,000

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

1,368,684⁷

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

30,000

WITH:

SHARED DISPOSITIVE POWER

1,368,684⁵

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,398,684

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

2.7%

TYPE OF REPORTING PERSON

⁷ Roberto Bellini and Carlo Bellini are deemed to share beneficial ownership of 1,368,684 Common Shares held by Rocabe.


CUSIP No.		07986A101	Schedule 13D	Page		9		of		24 pages

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Carlo Bellini

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS (SEE INSTRUCTIONS)

N/A

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

SOLE VOTING POWER

NUMBER OF

64,200

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

1,368,684⁸

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

64,200

WITH:

SHARED DISPOSITIVE POWER

1,368,684⁶

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,432,884

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

2.8%

TYPE OF REPORTING PERSON

⁸ Carlo Bellini and Roberto Bellini are deemed to share beneficial ownership of 1,368,684 Common Shares held by Rocabe.

TABLE OF CONTENTS


	ITEM 2. IDENTITY AND BACKGROUND
	ITEM 4. PURPOSE OF TRANSACTION
	ITEM 5. INTEREST IN SECURITIES OF THE COMPANY
	ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
SIGNATURE
EXHIBIT INDEX


CUSIP No. 07986A101		Schedule 13D		Page 10 of 24 pages

This Amendment No. 25 amends the Schedule 13D filed on October 3, 2003, as amended (the “Statement”), and is filed by (i) Picchio Pharma, Inc., (ii) FMRC Family Trust, (iii) John W. Churchill, (iv) Vernon H. Strang, (v) Victoria Square Ventures Inc., (vi) Dr. Francesco Bellini, (vii) Roberto Bellini and (viii) Carlo Bellini, relating to the common shares, no par value (the “BELLUS Shares” or “Common Shares”), of BELLUS Health Inc. (formerly known as Neurochem Inc.), a corporation organized under the Canada Business Corporations Act (the “Company”). Unless otherwise indicated, all capitalized terms used herein shall have the meanings given to them in the Statement, and unless amended hereby, all information previously filed remains in effect. All dollar amounts are in Canadian dollars, except as otherwise indicated.

This Amendment No. 25 is filed to report (i) the purchase of additional New Notes of the Company by each of VSV and Vitus pursuant to the terms of the Note Purchase Agreements between the Company and, respectively, VSV and Vitus, described in Amendments No. 23 and 24, (ii) the transfer of Common Shares owned by Luxco to Picchio, and (iii) a delay in the distribution of Common Shares from Picchio to Alberta and VSV.

ITEM 2. IDENTITY AND BACKGROUND

Item 2 is hereby amended by adding the following at the end thereof:

On May 25, 2009, Luxco was dissolved and its assets were transferred to Picchio.

ITEM 4. PURPOSE OF TRANSACTION

Item 6 is hereby incorporated in this Item 4. The transfer of Common Shares owned by Luxco to Picchio is part of a reorganization of interests held by the shareholders of Picchio in various entities, including the Company.

ITEM 5. INTEREST IN SECURITIES OF THE COMPANY

All references to 11,087,382 Common Shares held directly by Luxco are hereby amended to refer to such shares being held directly by Picchio.

Item 5(c) is hereby amended by adding the following at the end thereof:

On May 25, 2009, all 11,087,382 Common Shares held by Luxco were transferred to Picchio.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

Item 6 is hereby amended by adding the following at the end thereof:

Pursuant to the Note Purchase Agreements, on June 3, 2009, VSV purchased $5.5 million in principal amount, and Vitus purchased $5.0 million in principal amount, of additional New Notes of the Company. In addition, the Company also issued $307,500 in principal amount of New Notes to each of VSV and Vitus, in


CUSIP No. 07986A101		Schedule 13D		Page 11 of 24 pages

payment of a set-up fee under the Note Purchase Agreements. The terms of the New Notes are described in Amendments 23 and 24. The forms of the Note Purchase Agreements and the New Notes are set forth in Exhibits AAA and BBB included with Amendment No. 24 and are incorporated into this Item 6 by reference.

Pursuant to the Alberta Memorandum and Picchio Note to Alberta set forth in Exhibits OO and PP included with Amendment No. 21, Alberta expects to receive 5,725,215 Common Shares from Picchio on or before June 30, 2009 (instead of April 30, 2009 as previously disclosed). Pursuant to the VSV Memorandum and Picchio Note to VSV set forth in Exhibits QQ and RR included with Amendment No. 21, VSV expects to receive 5,725,214 Common Shares from Picchio on or before June 30, 2009 (instead of April 30, 2009 as previously disclosed).


CUSIP No. 07986A101		Schedule 13D		Page 12 of 24 pages

SIGNATURE

P P LUXCO HOLDINGS II SARL SC 13D/A